In addition, the distinct pattern of plasma levels of τ phosphorylated at Thr217 could discriminate AD from other neurodegenerative diseases and are therefore gaining attention as a potential biomarker for AD [15,16,17]. The gene discussed is TBXT; the disease is Alzheimer disease.